Advertisements



Tonix Pharmaceuticals Reports Third Quarter 2019 Financial Results and Operational Highlights

50% of Enrollment Complete for Phase 3 RECOVERY Trial of Tonmya® for the Treatment of PTSD Results from RECOVERY Interim Analysis Expected First Quarter 2020 Topline Data Expected Second Quarter 2020 Based on Cu.....»»

Category: earningsSource: benzingaNov 8th, 2019

Tonix Pharmaceuticals Reports Third Quarter 2019 Financial Results and Operational Highlights

50% of Enrollment Complete for Phase 3 RECOVERY Trial of Tonmya® for the Treatment of PTSD Results from RECOVERY Interim Analysis Expected First Quarter 2020 Topline Data Expected Second Quarter 2020 Based on Cu.....»»

Category: earningsSource: benzingaNov 8th, 2019

Tonix Pharmaceuticals Reports Second Quarter 2019 Financial Results and Operational Highlights

Enrollment Continues for Phase 3 RECOVERY Trial of Tonmya® for the Treatment of PTSD; Topline Data Expected First Half of 2020 Pipeline Expanded in Addiction Medicine with Cocaine .....»»

Category: earningsSource: benzingaAug 12th, 2019

Tonix Pharmaceuticals Reports First Quarter 2019 Financial Results and Operational Highlights

Tonix Pharmaceuticals Reports First Quarter 2019 Financial Results and Operational Highlights.....»»

Category: earningsSource: benzingaMay 13th, 2019

Tonix Pharmaceuticals Reports First Quarter 2020 Financial Results and Operational Highlights

Tonix Pharmaceuticals Reports First Quarter 2020 Financial Results and Operational Highlights.....»»

Category: earningsSource: benzingaMay 12th, 2020

Zynerba Pharmaceuticals Reports Fourth Quarter and Year End 2019 Financial Results and Operational Highlights

- Key Recent Clinical Milestones.....»»

Category: earningsSource: benzingaMar 10th, 2020

Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Operational Highlights

Phase 3 RECOVERY Trial of Tonmya® for the .....»»

Category: earningsSource: benzingaMar 18th, 2019

Zynerba Pharmaceuticals Reports Fourth Quarter and Year End 2018 Financial Results and Operational Highlights

DEVON, Pa., March 11, 2019 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innova.....»»

Category: earningsSource: benzingaMar 11th, 2019

Zynerba Pharmaceuticals Reports Fourth Quarter and Year End 2018 Financial Results and Operational Highlights

DEVON, Pa., March 11, 2019 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pha.....»»

Category: earningsSource: benzingaMar 11th, 2019

Zynerba Pharmaceuticals Reports First Quarter 2020 Financial Results and Operational Highlights

DEVON, Pa., May 11, 2020 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders.....»»

Category: earningsSource: benzingaMay 11th, 2020

BrainsWay Reports Fourth Quarter and Full-Year 2019 Financial Results and Operational Highlights

PATTERSON, N.J., March 23, 2020 (GLOBE NEW.....»»

Category: earningsSource: benzingaMar 23rd, 2020

BrainsWay Reports Third Quarter 2019 Financial Results and Operational Highlights

JERUSALEM, Isra.....»»

Category: earningsSource: benzingaNov 25th, 2019

RedHill Biopharma Reports Third Quarter 2019 Financial Results and Operational Highlights

RedHill Biopharma Reports Third Quarter 2019 Financial Results and Operational Highlights.....»»

Category: earningsSource: benzingaNov 19th, 2019

Ceapro Inc. Reports 2019 Third Quarter Financial Results and Operational Highlights

- Continued execution on transition to a new business model from contract manufacturer to biopharmaceutical company - - Maintai.....»»

Category: earningsSource: benzingaNov 13th, 2019

Spring Bank Pharmaceuticals Reports Third Quarter 2019 Financial and Operational Results and Provides Corporate Update

HOPKINTON, Mass., Nov. 07, 2019 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (NASDAQ:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, inflammato.....»»

Category: earningsSource: benzingaNov 7th, 2019

Ceapro Inc. Reports 2019 Second Quarter and Six-Month Financial Results and Operational Highlights

- Continued execution on transition to a new business model from contract manufacturer to biopharmaceutical compan.....»»

Category: earningsSource: benzingaAug 28th, 2019

Brainsway Reports Second Quarter 2019 Financial Results and Operational Highlights

JERUSALEM, Israel and HACKENSACK, N.J., Aug. 26, 2019 (GLOBE NEWSWIRE) -- Brainsway Ltd. (NASDAQ & TASE: BWAY) ("Brainsway" or the "Company"), a global leader in the advanced non-invasive treatment of brain disorders, today reporte.....»»

Category: earningsSource: benzingaAug 26th, 2019

Precision BioSciences Reports Second Quarter 2019 Financial Results and Highlights Ongoing Operational Progress

DURHAM, N.C., Aug. 14, 2019 (GLOBE NEWSWIRE) -- Precision BioSciences, Inc. (NASDAQ:DTIL) ("Precision"), a genome editing company dedicated to improving life through the application of its p.....»»

Category: earningsSource: benzingaAug 14th, 2019

Ionis Reports Second Quarter 2019 Financial Results

CARLSBAD, Calif., Aug. 7, 2019 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) today reported its financial results for the second quarter and year-to-date 2019 and recent business highlights. "We ente.....»»

Category: earningsSource: benzingaAug 7th, 2019

Spring Bank Pharmaceuticals Reports Second Quarter 2019 Financial and Operational Results and Provides Business Development Update

HOPKINTON, Mass., July 31, 2019 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (NASDAQ:SBPH), a clinical-stage biop.....»»

Category: earningsSource: benzingaJul 31st, 2019

Phio Pharmaceuticals Reports First Quarter 2019 Financial Results and Corporate Highlights

Phio Pharmaceuticals Reports First Quarter 2019 Financial Results and Corporate Highlights.....»»

Category: earningsSource: benzingaMay 14th, 2019